ALYMSYS vs TECENTRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate

Possible drug interaction. ALYMSYS and TECENTRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALYMSYS	TECENTRIQ
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB-MALY	ATEZOLIZUMAB
Manufacturer	Amneal	Genentech Inc
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

alymsys tecentriq

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB-MALY

ATEZOLIZUMAB

Manufacturer

Amneal

Genentech Inc

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Frequently asked questions

Which is better-rated, Alymsys or Tecentriq?

Alymsys and Tecentriq are tied at 3.6 out of 5 by our independent rating.

What is the difference between Alymsys and Tecentriq?

Alymsys contains Bevacizumab-Maly, while Tecentriq contains Atezolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.